ALung to Present at Mid-Atlantic Bio Conference

17 August 2012 Recent News

Bethesda, Maryland (August 17, 2012) – The Mid-Atlantic Bio Conference today named the more than 20 biotech companies that will formally present business innovations and growth strategies to an audience of more than 850 investors, scientists, advisors and professional service providers from the life sciences sector during this year’s Annual Conference on September 27-28, 2012.  (read more)

Regenerative Medicine Spin-Out Funds Research Fellowship

27 June 2012 Recent News

The McGowan Institute for Regenerative Medicine received a monetary gift award of $70,000 from ALung Technologies Inc. in support of a research fellowship in the area of respiratory assist devices. The award augments ongoing studies with the McGowan Institute for Regenerative Medicine-Medical Devices Laboratory headed by William Federspiel, PhD, the William Kepler Whiteford professor of bioengineering, (read more)

ALung Technologies Presents Positive Clinical Trial Results of the Hemolung Respiratory Assist System

18 June 2012 Press Release

Pilot study shows the potential of the Hemolung RAS to help reduce the need for invasive mechanical ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). PITTSBURGH, Pennsylvania, June 18, 2012 – ALung Technologies, Inc., a leading developer of innovative lung assist devices, presented an analysis of its recent clinical trial of (read more)

Respiratory Dialysis Could Replace Mechanical Ventilation

30 March 2012 Recent News

An innovative device overcomes the limitations of mechanical ventilation by performing respiratory gas exchange via blood dialysis in the femoral or jugular veins, removing half of retained CO2 while administering oxygen. (read more)

ALung Technologies Raises $10M in Series B Financing

6 February 2012 Press Release

PITTSBURGH–(BUSINESS WIRE)–ALung Technologies, Inc., a leading developer of advanced respiratory products, announced today that it has closed a $10 million Series B financing round. The investment will support the continued commercialization of ALung’s flagship product, the Hemolung® Respiratory Assist System (RAS), which provides partial respiratory assistance to patients in acute respiratory failure. The device is expected (read more)

ALung poised for sales in Germany

3 February 2012 Investment News, Recent News

Investors satisfaction leads to $10 million of additional fundraising as ALung prepares to enter the European medical device market. (read more)

Nick Kuhn, CBO of ALung, receives the 2012 Carnegie Science Center Start-Up Entrepreneur Award

2 February 2012 Awards, Recent News

The Carnegie Science Center will honor Nick Kuhn of ALung with it's 2012 "Start-Up Entrepreneur Award" on May 11, 2012. (read more)